BI-3812 free base · Synonyms: BI 3812 · BI3812
BI-3812 is potent and efficacious BCL6 inhibitor.
For research use only. Not for human or veterinary use.
Purity >98%
Stock Inquire
BI-3812 structure
CAS No.: 2166387-64-8
Pack sizes & pricing
Description
BI-3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of ≤3 nM; BI-3812 has antitumor activity.
Biological activity
In Vivo BI-3812 is a BCL6 inhibitor, with an IC50 of ≤ 3 nM. BI-3812 shows an IC50 of 40 nM for the cellular BCL6.
Identifiers
- SMILES
-
CNC(=O)COC1=CC2=C(N(C)C1=O)C(OC)=CC(NC1=NC(=NC=C1Cl)N1CCC(CC1)C(=O)N(C)C)=C2 - InChIKey
-
XCGYXEVLQIIEJH-UHFFFAOYSA-N
Specifications
- MW (average)
- 558.0290
- Formula
- C26H32ClN7O5
- CAS No.
- 2166387-64-8
- Physical state
- Solid
- Color
- Off-white to pink
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
[1]. Kerres N, et al. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6. Cell Rep. 2017 Sep 19;20(12):2860-2875.
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%